Rougemont Patents Lawyers

Ahaji Amos is an experienced intellectual property attorney, with a special focus on intellectual property prosecution and litigation in the biotechnological arts, including medical devices, supplements, pharmaceuticals, and software. Ahaji has handled all aspects of litigation, including first chairing multiple litigation matters, as well as handling quasi-litigation matters before the PTAB and TTAB.
Ahaji practices all aspects of intellectual property including patents, trademarks, trade secrets and copyrights. She has filed over 100 patent applications, over 100 trademark applications, and numerous cancelation and opposition proceedings. Because she primarily represents early-stage companies, Ahaji also regularly counsels clients on business...

Dr. A. Jamie Cuticchia, has over 20 years’ academic and industry experience leading groups in computational biology, genomics, high-performance computing, software engineering, and genome database construction. He has raised over $125,000,000 in research funding during his career. He has held numerous leadership positions including professorships at the Johns Hopkins University School of Medicine and the University of Toronto Faculty of Medicine. Dr. Cuticchia founded the Ontario Center for Genomic Computing, a Top 500 Supercomputing Center and the largest supercomputing center devoted solely to addressing issues of life sciences. He also held several full and part-time industrial...

After training initially with one of the top biotech patent groups in the U.S. and practicing in large general practice firms for over 20 years, Carl has the experience to meet the intellectual property needs of startups, mid-size R&D companies, large biotherapeutic and pharmaceutical companies, and top tier, research-intensive universities. He enjoys doing single-project work, as well as comprehensive counseling and portfolio development for startups and growing companies.

Carl counsels scientific founders on initial protection strategies for their platform technology (timing, scope of disclosure, landscape analysis, ownership issues), develops licensing programs for biotechnology, and evaluates lifecycle management programs for marketed human...